Business Wire

HISENSE

1.6.2021 12:00:08 CEST | Business Wire | Press release

Share
Building Sustainable Future: Hisense and Employees

Living under the new-normal, ESG has become one of the world's most trending topics. A positive impact on society and providing sustainable development opportunities for employees have gradually become the new criteria for companies to represent their growth. By putting talent first, Hisense strives to build a global team that includes people from different cultures and unique experiences, and to provide an equal and healthy working environment to drive its success. Together with over 90,000 employees around the world, Hisense is creating a sustainable future and exerting positive social influence constantly.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210601005474/en/

Focusing on local talent cultivation and cultural inclusion

Hisense supports local communities to relieve their unemployment pressure and to reduce the indirectly related crime rate. Through its investment in industrial parks worldwide, Hisense creates more than 3,000 job positions in South Africa and over 2,000 in Mexico with an expectation to expand to over 7,000 in the future, which successfully helps the local region expand its economy and boost sustainable development.

Hisense provides equal employment opportunities regardless of race and gender with professional and systematic training when recruiting local employees. For example, Nicalette, a single mother, who joined Hisense South Africa in 2002, was promoted to After-sales Manager through her excellent work performance and rapidly growing ability. Hisense’s talent employment and cultivation system has increased her passion for work and also made her life improved, according to Nicalette.

Caring for employees' career development

To empower employees, Hisense has created the necessary conditions and space for them to maximize their potential and value. Hisense implements a flexible promotion mechanism, allowing employees to choose between career paths of “management” and “R&D” for further development, which ensures a smooth promotion channel for everyone.

Hisense College, the corporate university, aims to help employees achieve better career development. A comprehensive training structure and multiple internal training platforms (including offline lecture, website, APP, etc.) are in place to help employees learn and improve anytime, anywhere.

"What makes working here different from other companies is that Hisense always motivates its employees to accomplish career goals and gives them great supports, allowing them to grow with the company." said Robin Silberbauer, who joined Hisense South Africa in 2015.

Caring for employees' health and wellbeing

During the pandemic, Hisense spares no efforts to assure employees' and their families' health through distributing epidemic prevention materials and supporting working at home.

Hisense also joins hands with professional EAP (“Employee Assistance Program”) organizations to provide mental health care for employees and their families, so that each employee can easily obtain professional psychological counselling services, which efficiently help them improve mental health and take up challenges of work and life.

Hisense will focus on talent development in the long term and actively create an inclusive workplace environment to advance the sustainable development of local communities with its global workforce.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye